NetworkNewsBreaks – PreveCeutical Medical Inc. (
Post# of 77
Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning issued a shareholder update on its ongoing corporate initiatives. Among the highlights discussed in the news release, the company entered into a natural health product licensing agreement with Asterion Cannabis Inc., launched its medicinal cannabis division, completed a $6.5 million financing and expanded its Australian operations. As noted, these milestones serve as evidence of PreveCeutical’s continued execution of its strategy to become a global preventative health care company.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer